Small-Molecule Drugs
Spironolactone
Last reviewed: 2026-11-19
Overview
A steroidal mineralocorticoid-receptor antagonist.
Regulatory status
FDA approval applies only to the named products and indications below. It does not approve every formulation or other use.
Aldactone · Cardiovascular Care
Specified heart failure, hypertension and edema indications; not FDA-approved for hair loss or acne.
Authoritative label recordAldactone · Endocrine Disorders
Primary hyperaldosteronism under labeled conditions.
Authoritative label record
Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.
WADA prohibited status: current list and contextEvidence at a glance
Approved cardiovascular and endocrine uses do not constitute FDA approval for hair-loss or acne indications.
Key sources
Indication-specific regulatory sources and editorial screen checked November 19, 2026. This is not an exhaustive systematic review; consult current labels.
Related compounds
- Apomorphine
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Finasteride
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Metformin
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Methylthioninium chloride
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Minoxidil
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications